Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
RNA Sequencing
100%
Real-Time Polymerase Chain Reaction
100%
Glucose Metabolism
100%
Transcriptomics
100%
RNA Polymerase
50%
Interleukin-1
50%
Cotransporter
50%
Promoter Region
50%
Gene Expression Level
50%
Interleukin 6
50%
Glucose Blood Level
50%
Insulin Signaling
50%
High Density Lipoprotein Cholesterol Level
50%
Wistar Rat
50%
Low Density Lipoprotein Cholesterol Level
50%
Lipid Metabolism
50%
Gene Expression Assay
50%
Interleukin 8
50%
Keyphrases
Novel Pathways
100%
Type 2 Diabetic Rats
100%
Empagliflozin
100%
Liver Transcriptome
100%
Type 2 Diabetes Mellitus (T2DM)
44%
RNA Sequencing (RNA-seq)
22%
Liver
11%
Interleukin-1β
11%
Beneficial Effects
11%
Quantitative PCR
11%
High-density Lipoprotein Cholesterol (HDL-C)
11%
Cholesterol
11%
Triglycerides
11%
Gene Expression Level
11%
Interleukin-6
11%
Wistar Rats
11%
High-fat Diet
11%
Insulin Signaling
11%
Cardiovascular Disease
11%
Blood Glucose
11%
RNA Polymerase II (RNAPII)
11%
Liver Samples
11%
Inflammatory Factors
11%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
11%
Transcriptome Analysis
11%
Serum Samples
11%
Novel Inhibitors
11%
Solid Foundation
11%
Negative Regulation
11%
Lipid Metabolism
11%
Interleukin-8
11%
Streptozotocin
11%
Acid Density
11%
Transcription Regulation
11%
Type 2 Diabetes Model
11%
Non-esterified Fatty Acids
11%
SGLT Inhibitors
11%
Sodium-glucose Cotransporter
11%
Glucolipid Metabolism
11%
Biochemical Indicators
11%
Metal Binding
11%
Hepatic Glucose Metabolism
11%
High-glucose Diet
11%
Liver Glucose Metabolism
11%
Metabolism Disease
11%
Binding Pathway
11%
Hepatic Metabolism
11%
Low-density Lipoprotein Cholesterol Level
11%
Downregulated Genes
11%
Upregulated Genes
11%
Medicine and Dentistry
Transcriptomics
100%
Empagliflozin
100%
Maturity Onset Diabetes of the Young
55%
Glucose Metabolism
22%
Real-Time Polymerase Chain Reaction
22%
RNA Sequencing
22%
Cardiovascular Disease
11%
Gene Expression Profiling
11%
Gene Expression
11%
Antidiabetic Agent
11%
Low Density Lipoprotein Cholesterol
11%
Promoter Region
11%
High Density Lipoprotein Cholesterol
11%
Triacylglycerol
11%
Fatty Acid
11%
Glucose Intake
11%
Insulin Signaling
11%
Streptozocin
11%
Sodium Glucose Cotransporter
11%
Blood Glucose
11%
Interleukin-1
11%
Metal Ion
11%
Lipid Metabolism
11%
Interleukin 6
11%
RNA Polymerase II
11%
High Fat Food
11%
Pharmacology, Toxicology and Pharmaceutical Science
Empagliflozin
100%
Non Insulin Dependent Diabetes Mellitus
55%
Streptozotocin
11%
Wistar Rat
11%
Antidiabetic Agent
11%
Low Density Lipoprotein Cholesterol
11%
Triacylglycerol
11%
Fatty Acid
11%
High Density Lipoprotein Cholesterol
11%
Sodium Glucose Cotransporter
11%
RNA Polymerase II
11%
Interleukin 6
11%
Transcriptome
11%
Cardiovascular Disease
11%
Metal Ion
11%